Grifols SA

자세한 내용은 Grifols SA 회사

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.

회사 정보

종목 코드 GRFS

회사 이름Grifols SA

상장일May 17, 2006

CEOMr. Jose Ignacio (Nacho) Abia

직원 수23833

유형Depository Receipt

회계 연도 종료May 17

주소Parque Empresarial Can Sant Joan

도시SANT CUGAT DEL VALLES

증권 거래소NASDAQ Global Select Consolidated

국가Spain

우편 번호08174

전화34935710000

웹사이트https://www.grifols.com/

종목 코드 GRFS

상장일May 17, 2006

CEOMr. Jose Ignacio (Nacho) Abia

회사 임원

이름

이름/직위

직위

주식 보유

변동

Ms. Laura De La Cruz Galan

Non-Member Assistant Secretary of the Board

--

Ms. Nuria Martin Barnes

Non-Member Secretary of the Board of Directors

--

Mr. Joerg Schuettrumpf

Chief Scientific Innovation Officer

--

Mr. Paul S. Herendeen

Proprietary Director

--

Mr. Daniel Fleta Coit

Chief Industrial Services Officer

--

Mr. Victor Grifols Deu

Proprietary Director

--

Ms. Montserrat Munoz Abellana

Independent Director

--

Mr. Inigo Sanchez-Asiain Mardones

Independent Director

--

Ms. Susana Gonzalez Rodriguez

Independent Director

--

Mr. Jordi Balsells Valls

President - Plasma Procurement

--

이름

이름/직위

직위

주식 보유

변동

Ms. Laura De La Cruz Galan

Non-Member Assistant Secretary of the Board

--

Ms. Nuria Martin Barnes

Non-Member Secretary of the Board of Directors

--

Mr. Joerg Schuettrumpf

Chief Scientific Innovation Officer

--

Mr. Paul S. Herendeen

Proprietary Director

--

Mr. Daniel Fleta Coit

Chief Industrial Services Officer

--

Mr. Victor Grifols Deu

Proprietary Director

--

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q2

FY2021

FY2020

FY2019

데이터 없음

지역별USD

이름

수익

비율

United States/Canada

4.42B

56.67%

Rest of the World

1.71B

21.96%

European Union

1.21B

15.50%

Spain

457.59M

5.87%

사업별

지역별

데이터 없음

주식 보유 통계

마지막 업데이트: Fri, May 16

주주

주주 유형

주주

비율

Brandes Investment Partners, L.P.

9.97%

Capital World Investors

8.33%

Permian Investment Partners, LP

7.00%

Black Creek Investment Management, Inc.

4.91%

Armistice Capital LLC

3.59%

Other

66.19%

주주

비율

Brandes Investment Partners, L.P.

9.97%

Capital World Investors

8.33%

Permian Investment Partners, LP

7.00%

Black Creek Investment Management, Inc.

4.91%

Armistice Capital LLC

3.59%

Other

66.19%

주주 유형

주주

비율

Investment Advisor

27.38%

Hedge Fund

18.23%

Investment Advisor/Hedge Fund

6.83%

Research Firm

4.06%

Pension Fund

1.13%

Sovereign Wealth Fund

0.75%

Bank and Trust

0.14%

Family Office

0.03%

Other

41.44%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

304

150.62M

58.33%

-8.38M

2025Q1

318

151.56M

58.69%

-8.09M

2024Q4

317

145.36M

56.29%

-25.01M

2024Q3

302

144.07M

55.96%

-19.66M

2024Q2

298

148.36M

57.63%

-6.71M

2024Q1

295

140.29M

54.61%

+6.03M

2023Q4

303

126.55M

49.26%

-7.36M

2023Q3

316

123.59M

48.19%

-7.60M

2023Q2

331

119.70M

46.67%

-25.54M

2023Q1

347

120.97M

47.21%

-11.90M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Brandes Investment Partners, L.P.

25.74M

9.97%

+5.25M

+25.59%

Mar 31, 2025

Capital World Investors

21.52M

8.33%

+388.01K

+1.84%

Mar 31, 2025

Permian Investment Partners, LP

18.08M

7%

+1.89M

+11.70%

Mar 31, 2025

Black Creek Investment Management, Inc.

12.69M

4.91%

+1.44M

+12.79%

Mar 31, 2025

Armistice Capital LLC

9.28M

3.59%

-758.00K

-7.55%

Mar 31, 2025

Millennium Management LLC

8.57M

3.32%

-783.49K

-8.38%

Mar 31, 2025

Soleus Capital Management, L.P.

7.09M

2.75%

+484.40K

+7.33%

Mar 31, 2025

Goldman Sachs & Company, Inc.

3.66M

1.42%

+275.63K

+8.15%

Mar 31, 2025

Harris Associates L.P.

3.44M

1.33%

-284.90K

-7.65%

Mar 31, 2025

Janus Henderson Investors

3.05M

1.18%

--

Mar 31, 2025

관련 ETF

마지막 업데이트: Sat, Aug 2

이름

비율

Brandes US Small-Mid Cap Value ETF

1.82%

Brandes International ETF

1.72%

Capital Group International Core Equity ETF

0.23%

iShares Biotechnology ETF

0.15%

ProShares Ultra Nasdaq Biotechnology

0.12%

Invesco Nasdaq Biotechnology ETF

0.12%

SPDR S&P Kensho New Economies Composite ETF

0.04%

ActivePassive International Equity ETF

0.03%

SPDR Portfolio Developed World ex-US ETF

0.01%

Fidelity Nasdaq Composite Index ETF

0.01%

Brandes US Small-Mid Cap Value ETF

비율1.82%

Brandes International ETF

비율1.72%

Capital Group International Core Equity ETF

비율0.23%

iShares Biotechnology ETF

비율0.15%

ProShares Ultra Nasdaq Biotechnology

비율0.12%

Invesco Nasdaq Biotechnology ETF

비율0.12%

SPDR S&P Kensho New Economies Composite ETF

비율0.04%

ActivePassive International Equity ETF

비율0.03%

SPDR Portfolio Developed World ex-US ETF

비율0.01%

Fidelity Nasdaq Composite Index ETF

비율0.01%

주식 배당금

지난 5년 동안 총 436.88M USD의 배당금이 분배되었습니다.

날짜

배당금

기준일

지급일

배당락일

May 25, 2021

GRFS.NB Interim Cash Dividend of gross USD 0.456586 paid on Jun 14, 2021 going ex on Jun 03, 2021

Jun 04, 2021

Jun 14, 2021

Jun 03, 2021

Oct 23, 2020

GRFS.NB Interim Cash Dividend of gross USD 0.201439 paid on Nov 09, 2020 going ex on Oct 30, 2020

Nov 02, 2020

Nov 09, 2020

Oct 30, 2020

주식 분할

날짜

유형

비율

데이터 없음

날짜

유형

비율

데이터 없음

10.835USD

Grifols SA

10.835

개요

회사

금융